Literature DB >> 33159560

A Multidisciplinary Lung Cancer Program: Does It Reduce Delay Between Diagnosis and Treatment?

Denise Albano1, Thomas Bilfinger1, Melissa Feraca2, Stephen Kuperberg2, Barbara Nemesure3.   

Abstract

INTRODUCTION: Lung cancer is the leading cause of cancer death in the USA, claiming more than 140,000 deaths annually. Delays in diagnosis and treatment can lead to missed opportunities for both curative and life prolonging therapies. This study aimed to evaluate duration of time to diagnosis and first treatment, as well as investigate reasons for delays in care.
METHODS: This retrospective study included all lung cancer cases diagnosed by Stony Brook's Lung Cancer Evaluation Center (LCEC) between 2013 and 2019. Demographic, radiologic, pathologic and clinical variables were investigated, including cancer staging, histology, and medical and family histories. Evaluations included the determination of median time from initial encounter to diagnosis, median time from diagnosis to start of treatment and an exploration of the factors that influence possible causes for delays in care.
RESULTS: The LCEC's comprehensive multidisciplinary lung nodule program yielded a median length of time from CT to PET of 11 days, PET to procedure of 13 days, procedure to treatment consult of 9 days, and from consult to treatment of 9 days. LCEC patients experienced an overall median of 44 days from initial presentation to first treatment compared to the national ideal of 62 days, thereby representing a 29% reduction in time from first CT to onset of treatment.
CONCLUSION: Delays in lung cancer diagnosis and treatment can negatively impact patient morbidity and mortality. This study suggests that a coordinated multidisciplinary lung cancer program may reduce delays in care, thereby improving patient outcomes.

Entities:  

Keywords:  Barriers to care; Delay in care; Diagnosis; Lung cancer; Multidisciplinary care

Year:  2020        PMID: 33159560     DOI: 10.1007/s00408-020-00404-8

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  21 in total

1.  Killing time: the consequences of delays in radiotherapy.

Authors:  William J Mackillop
Journal:  Radiother Oncol       Date:  2007-06-14       Impact factor: 6.280

2.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

3.  Beliefs among physicians in the diagnostic and therapeutic approach to non-small cell lung cancer.

Authors:  Thomas E Stinchcombe; Frank C Detterbeck; Li Lin; M Patricia Rivera; Mark A Socinski
Journal:  J Thorac Oncol       Date:  2007-09       Impact factor: 15.609

4.  Delays in the diagnosis of lung cancer.

Authors:  Peter M Ellis; Rachel Vandermeer
Journal:  J Thorac Dis       Date:  2011-09       Impact factor: 2.895

5.  Delay in diagnosis of lung cancer in general practice.

Authors:  Marianne Bjerager; Torben Palshof; Ronald Dahl; Peter Vedsted; Frede Olesen
Journal:  Br J Gen Pract       Date:  2006-11       Impact factor: 5.386

6.  Delays in the diagnosis and treatment of lung cancer.

Authors:  Eija-Riitta Salomaa; Susanna Sällinen; Heikki Hiekkanen; Kari Liippo
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

7.  Typical Time to Treatment of Patients With Lung Cancer in a Multisite, US-Based Study.

Authors:  Regina M Vidaver; Marianna B Shershneva; Scott J Hetzel; Timothy R Holden; Toby C Campbell
Journal:  J Oncol Pract       Date:  2016-05-03       Impact factor: 3.840

8.  Disparities in timeliness of care for U.S. Medicare patients diagnosed with cancer.

Authors:  M T Halpern; D J Holden
Journal:  Curr Oncol       Date:  2012-12       Impact factor: 3.677

9.  Shame, guilt, and communication in lung cancer patients and their partners.

Authors:  D Dirkse; L Lamont; Y Li; A Simonič; G Bebb; J Giese-Davis
Journal:  Curr Oncol       Date:  2014-10       Impact factor: 3.677

10.  Pathways to the diagnosis of lung cancer in the UK: a cohort study.

Authors:  Jacqueline Barrett; William Hamilton
Journal:  BMC Fam Pract       Date:  2008-05-18       Impact factor: 2.497

View more
  1 in total

1.  LUNG Year in Review: 2020.

Authors:  Peter V Dicpinigaitis
Journal:  Lung       Date:  2021-01-26       Impact factor: 2.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.